WEC
Winslow Evans & Crocker’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $531K | Buy |
14,425
+7,560
| +110% | +$278K | 0.1% | 194 |
|
2020
Q3 | $258K | Sell |
6,865
-349
| -5% | -$13.1K | 0.06% | 243 |
|
2020
Q2 | $294K | Sell |
7,214
-6
| -0.1% | -$245 | 0.08% | 231 |
|
2020
Q1 | $274K | Buy |
7,220
+324
| +5% | +$12.3K | 0.09% | 207 |
|
2019
Q4 | $324K | Hold |
6,896
| – | – | 0.08% | 229 |
|
2019
Q3 | $296K | Sell |
6,896
-4
| -0.1% | -$172 | 0.08% | 241 |
|
2019
Q2 | $278K | Sell |
6,900
-302
| -4% | -$12.2K | 0.08% | 250 |
|
2019
Q1 | $302K | Buy |
7,202
+592
| +9% | +$24.8K | 0.09% | 230 |
|
2018
Q4 | $254K | Hold |
6,610
| – | – | 0.09% | 229 |
|
2018
Q3 | $266K | Hold |
6,610
| – | – | 0.08% | 232 |
|
2018
Q2 | $268K | Sell |
6,610
-350
| -5% | -$14.2K | 0.08% | 219 |
|
2018
Q1 | $272K | Hold |
6,960
| – | – | 0.09% | 216 |
|
2017
Q4 | $247K | Sell |
6,960
-378
| -5% | -$13.4K | 0.08% | 229 |
|
2017
Q3 | $298K | Sell |
7,338
-415
| -5% | -$16.8K | 0.1% | 201 |
|
2017
Q2 | $334K | Sell |
7,753
-1
| -0% | -$43 | 0.09% | 234 |
|
2017
Q1 | $327K | Buy |
7,754
+350
| +5% | +$14.8K | 0.1% | 210 |
|
2016
Q4 | $285K | Sell |
7,404
-7,976
| -52% | -$307K | 0.09% | 238 |
|
2016
Q3 | $663K | Buy |
15,380
+8,006
| +109% | +$345K | 0.19% | 113 |
|
2016
Q2 | $320K | Buy |
7,374
+1
| +0% | +$43 | 0.1% | 204 |
|
2016
Q1 | $299K | Buy |
7,373
+99
| +1% | +$4.01K | 0.09% | 205 |
|
2015
Q4 | $293K | Hold |
7,274
| – | – | 0.08% | 232 |
|
2015
Q3 | $280K | Hold |
7,274
| – | – | 0.09% | 225 |
|
2015
Q2 | $303K | Sell |
7,274
-784
| -10% | -$32.6K | 0.09% | 235 |
|
2015
Q1 | $372K | Hold |
8,058
| – | – | 0.11% | 206 |
|
2014
Q4 | $344K | Hold |
8,058
| – | – | 0.1% | 208 |
|
2014
Q3 | $370K | Buy |
8,058
+501
| +7% | +$23K | 0.11% | 207 |
|
2014
Q2 | $404K | Sell |
7,557
-159
| -2% | -$8.5K | 0.13% | 175 |
|
2014
Q1 | $412K | Sell |
7,716
-400
| -5% | -$21.4K | 0.14% | 163 |
|
2013
Q4 | $433K | Buy |
+8,116
| New | +$433K | 0.15% | 167 |
|